US drug launch for Vernalis
Vernalis, the biotechnology company, is finally to see its migraine drug, Frovatriptan, launched in the US, following an agreement between Elan, which holds distribution rights for the product and a
Vernalis, the biotechnology company, is finally to see its migraine drug, Frovatriptan, launched in the US, following an agreement between Elan, which holds distribution rights for the product and a